Dr. Gevirtz is Medical Director, Somnia Inc, 450 Mamaroneck Ave #201, Harrison, NY 10528; and Adjunct Associate Professor of Anesthesiology, Louisiana State University, New Orleans, Louisiana; E-mail: [email protected].
All authors, faculty, and staff have no relevant financial relationship with any ineligible organizations regarding this educational activity.
Tecovirimat and brincidofovir are discussed in off-label use, but they are approved for emergency use by the FDA.
CME Accreditation
Lippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation assessment survey on the enclosed form, answering at least 70% of the quiz questions correctly. This CME activity expires on December 31, 2024.
NCPD Accreditation
Lippincott Professional Development is accredited as a provider of nursing continuing professional development (NCPD) by the American Nurses Credentialing Center's Commission on Accreditation. Lippincott Professional Development will award 2.0 contact hours for this NCPD activity. This activity has been assigned 1.5 pharmacology credits. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.0 contact hours. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, West Virginia, New Mexico, South Carolina, and Florida, CE Broker #50-1223. Your certificate is valid in all states. Instructions for earning ANCC contact hours are included on page 11 of the newsletter. This NCPD activity expires on December 5, 2025.
